Kwara Lenacapavir HIV injection rollout begins as state offers free twice-yearly drug to prevent infections and boost HIV control
The Kwara State Government has launched a free long-acting HIV prevention injection, introducing Lenacapavir as part of a strategic push to reduce new infections and strengthen public health outcomes across the state.
Also read: Seun Kuti alleges 13-year industry blacklisting
The rollout, held at the Kwara State University Teaching Hospital, marks a significant shift towards more convenient prevention methods, with the drug administered twice yearly as pre-exposure prophylaxis for individuals at risk.
The Kwara Lenacapavir HIV injection initiative forms part of the Federal Government of Nigeria’s broader goal to end AIDS as a public health threat by 2030, with the state among eight selected for the initial phase alongside the Federal Capital Territory.
Speaking at the event, Amina El-Imam, Commissioner for Health, described the launch as a powerful milestone in HIV prevention efforts.
“This marks not just the introduction of a new medical intervention, but a bold step forward in our collective fight against HIV,” she said.
El-Imam noted that while progress has been made in testing and treatment, prevention gaps remain, particularly among vulnerable and high-risk populations.
Lenacapavir works by targeting the HIV capsid to block viral replication and offers protection for up to six months per dose, addressing longstanding challenges with adherence to daily oral medication.
“This innovation is especially promising for populations who face barriers to daily oral PrEP, including stigma and limited access to healthcare services,” she added.
The state government said the programme would be integrated into broader health strategies, including expanded community outreach and strengthened primary healthcare systems.
Also speaking, Oluwatosin Fakayode, Director of Public Health, described the rollout as another step forward in reducing HIV prevalence in the state.
“Lenacapavir is an innovative tool and an addition to what we have in our preventive arsenal,” he said.
The Kwara Lenacapavir HIV injection is targeted at HIV-negative individuals at substantial risk, including those in sero-discordant relationships, according to O N Omede of the Society for Family Health.
He emphasised that the injection does not replace other preventive measures and does not protect against other sexually transmitted infections.
The Federal Government began distributing the drug in March 2026, securing about 52,000 doses for the initial phase.
The medication, also known globally as Sunlenca, is being provided free of charge in public health facilities.
Also read: Evans Okoro tests negative after HIV rumour
Health officials say the introduction of the twice-yearly injectable represents a decisive evolution from daily oral prevention to more sustainable biomedical solutions, positioning Kwara at the forefront of innovative HIV control strategies in Nigeria.
